Hematological Malignancies Clinical Trials in New York, New York
3 recruitingNew York, New York
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Janssen Research & Development, LLC510 enrolled78 locationsNCT04634552
Recruiting
Phase 1Phase 2
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Hematological Malignancies
Daiichi Sankyo420 enrolled4 locationsNCT07220616
Recruiting
Phase 1Phase 2
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
Hematological Malignancies
Smart Immune SAS36 enrolled1 locationNCT04959903